
OHI Stock Forecast & Price Target
OHI Analyst Ratings
Bulls say
Omega Healthcare Investors Inc. has revised its 2025 funds from operations (FFO) estimate upward to $2.81 per share, reflecting a stronger investment volume than previously anticipated. Additionally, the normalized FFO estimate has been increased to $2.95 per share, enhancing confidence in the company's operational performance. With a year-to-date stock performance of +12%, significantly outpacing the +4% return of the VNQ index, Omega is also trading near the upper end of its 10-year valuation range, indicating strong market positioning and financial prospects.
Bears say
Omega Healthcare Investors Inc. faces significant challenges stemming from operator difficulties within the long-term healthcare sector, which contribute to a cautious outlook on the company's performance. Additionally, concerns regarding the company's relative valuation persist amid these operator challenges, hindering a more optimistic assessment. While the company's adjusted funds from operations (FFO) estimate for 2026 has slightly increased to $3.22 per share, it remains uncertain whether this growth will alleviate the broader concerns affecting its stock.
This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.
OHI Analyst Forecast & Price Prediction
Start investing in OHI
Order type
Buy in
Order amount
Est. shares
0 shares